Streetbeat News

Price Targets

CR

Vertical Research analyst Jeffrey Sprague has initiated coverage on Crane Co. (NYSE:CR) with a Hold rating and set a price target of $110.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 4:23 pm

DELL

Melius Research analyst Ben Reitzes has initiated coverage on Dell Technologies (NYSE:DELL) with a Buy rating and set a price target of $95.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 4:21 pm

BHVN

JP Morgan analyst Tessa Romero has maintained an Overweight rating on Biohaven (NYSE:BHVN) and increased the price target from $26 to $32.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 4:08 pm

BLNK

HC Wainwright & Co. analyst Sameer Joshi has reiterated a Buy rating on Blink Charging (NASDAQ:BLNK) and maintained a $25 price target on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 4:05 pm

SPB

Canaccord Genuity analyst Brian McNamara has maintained a Buy rating on Spectrum Brands Holdings (NYSE:SPB) but has reduced the price target from $94 to $83.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 4:02 pm

BCRX

BioCryst Pharma (NASDAQ:BCRX) has received updated analyst ratings in the last quarter, with 1 bullish and 3 somewhat bullish ratings. The average 12-month price target for BCRX is $10.5, with a high of $12.00 and a low of $10.00, marking a 16.67% increase from the previous target of $9.00. Analysts base their ratings on financial predictions and company performance metrics.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 4:00 pm

UNH

Analysts have recently rated UnitedHealth Group (NYSE:UNH) with 1 bullish, 4 somewhat bullish, and 3 indifferent ratings. The average price target is $570.5, representing an upside from the current price of $534.02. This target has increased by 0.69% from the previous target of $566.60. Analyst ratings are based on predictions of a company's future earnings and revenue, and are updated quarterly or after major company events.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 4:00 pm

ALKS

Alkermes (NASDAQ:ALKS) has received mixed analyst ratings in the last quarter, with 1 bullish, 1 somewhat bullish, and 2 indifferent ratings. The average price target among these analysts is $33.5, which represents an upside from the current price of $24.24. This target has decreased by 9.46% from the previous target of $37.00. Analysts typically review stocks quarterly or after major company updates, considering factors like future earnings and revenue predictability.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 4:00 pm

QS

QuantumScape (NYSE:QS) has received mixed analyst ratings in the last quarter, with an average 12-month price target of $7.00, representing a 12.5% decrease from the previous target of $8.00. Ratings include 1 somewhat bullish, 2 indifferent, and 1 bearish. Analysts provide these ratings based on financial analysis and company insights, and they are updated quarterly.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 4:00 pm

PENN

Analysts have recently rated PENN Entertainment (NASDAQ:PENN) with 3 bullish and 5 indifferent ratings. The average price target is $27.25, which is 5.37% above the current price of $25.86. This target has decreased by 8.16% from the previous target of $29.67. Analyst ratings are provided quarterly and are based on financial analysis and insider information.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 4:00 pm